Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Researchers Receive Commercialization Grant to Develop Viral Inhibitors
Campus News

Researchers Receive Commercialization Grant to Develop Viral Inhibitors

By Sarah PlumridgeFeb 16, 2015
Share
Facebook Twitter Email
Jonathan Leis, PhD, professor in Microbiology-Immunology, received a grant to support his research on small molecule inhibitors that block the replication of enveloped viruses such as herpes and HIV.

Jonathan Leis, PhD, professor in Microbiology-Immunology, received an IllinoisVentures grant, a University of Illinois fund that supports the commercialization of new technologies, for his research on small molecule inhibitors that block the replication of enveloped viruses such as herpes and HIV.

Leis’ research focuses on the basic mechanisms of how viruses bud from cells, which allows the virus to leave the host cell and spread infection.

“We wanted to see if we could find small molecule inhibitors to disrupt the mechanism of virus release by disrupting the budding process,” said Leis, one of five researchers to receive grants from IllinoisVentures. “If we can disrupt the process leaving virus particles attached to the cell membrane then the virus can’t easily spread to infect other cells.   This would amount to the development of broad-based antiviral agents.”

Leis’ laboratory has identified several compounds that block the release of retroviruses from tissue culture cells.

“This small grant funding allows us to make analogs of our lead compound, which we can then test to see if it is a more potent antiviral agent without increasing its cell toxicity,” he said.

If successful, this will lead to testing the drug in animal studies.

IllinoisVentures is a joint effort by Argonne National Laboratory, Illinois Institute of Technology, Northern Illinois University, Northwestern University, Southern Illinois University, University of Chicago, University of Illinois at Chicago, and University of Illinois at Urbana-Champaign, as well as the Illinois Department of Commerce and Economic Opportunity and the Illinois Science & Technology Coalition.

Biochemistry Microbiology Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.